aTyr Pharma reported $2.79M in Stock for its fiscal quarter ending in March of 2026.





Stock Change Date
Ardelyx USD 128.02M 110.29M Mar/2026
aTyr Pharma USD 2.79M 67.83K Mar/2026
Biogen USD 2.38B 435.3M Jun/2026
Bristol-Myers Squibb USD 2.74B 19M Jun/2026
Cipla INR 65.97B 4.37B Mar/2026
Clal Biotechnology ILS 4.44M 0 Mar/2021
CSL USD 6.47B 327M Jun/2025
GlaxoSmithKline GBP 6.16B 233M Mar/2026
Grifols EUR 3.56B 63.19M Dec/2024
Lakefront Biotherapeutics EUR 17.69M 4.8M Mar/2026
Novartis USD 6.22B 66M Jun/2026
Roche Holding CHF 7.6B 9M Jun/2025
United Therapeutics USD 193.8M 15.5M Jun/2026